China National Accord Medicines Corporation Ltd. (SHE: 000028)
China flag China · Delayed Price · Currency is CNY
27.95
-1.26 (-4.31%)
Oct 11, 2024, 3:04 PM CST

China National Accord Medicines Corporation Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
14,50914,93713,16414,70618,13118,279
Upgrade
Market Cap Growth
-25.00%13.47%-10.48%-18.89%-0.81%9.28%
Upgrade
Enterprise Value
19,86120,00815,57718,36719,30717,056
Upgrade
Last Close Price
27.9528.3924.4426.9232.6531.93
Upgrade
PE Ratio
10.289.899.1511.2212.9814.02
Upgrade
PS Ratio
0.210.200.180.220.300.35
Upgrade
PB Ratio
0.870.710.680.821.071.17
Upgrade
P/FCF Ratio
7.505.715.8811.4515.0010.38
Upgrade
P/OCF Ratio
6.985.095.148.8812.079.08
Upgrade
EV/Sales Ratio
0.270.270.210.270.320.32
Upgrade
EV/EBITDA Ratio
5.707.806.138.209.179.24
Upgrade
EV/EBIT Ratio
9.868.526.789.049.969.95
Upgrade
EV/FCF Ratio
9.587.656.9614.3015.979.69
Upgrade
Debt / Equity Ratio
0.360.260.230.270.250.27
Upgrade
Debt / EBITDA Ratio
2.231.441.221.461.441.65
Upgrade
Debt / FCF Ratio
3.762.061.963.723.542.35
Upgrade
Asset Turnover
1.481.671.721.661.621.68
Upgrade
Inventory Turnover
7.838.408.358.689.279.93
Upgrade
Quick Ratio
1.111.111.061.021.101.25
Upgrade
Current Ratio
1.441.491.511.421.441.59
Upgrade
Return on Equity (ROE)
8.20%9.69%9.46%8.75%10.60%10.04%
Upgrade
Return on Assets (ROA)
2.48%3.25%3.36%3.08%3.29%3.40%
Upgrade
Return on Capital (ROIC)
4.47%5.85%6.16%5.77%5.93%5.79%
Upgrade
Earnings Yield
9.73%10.71%11.29%9.09%7.73%6.94%
Upgrade
FCF Yield
13.33%17.51%17.00%8.74%6.67%9.63%
Upgrade
Dividend Yield
2.33%2.40%2.52%1.71%1.89%1.45%
Upgrade
Payout Ratio
36.97%34.96%38.62%45.68%39.23%38.89%
Upgrade
Buyback Yield / Dilution
0.21%-0.00%---
Upgrade
Total Shareholder Return
2.54%2.40%2.52%1.71%1.89%1.45%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.